Year: 2018
Type: review
Abstract: The gastrointestinal tract is a site of high immune challenge, as it must maintain a delicate balance between tolerating luminal contents and generating an immune response towards pathogens. CD4+ T cells are key in mediating the host protective and homeostatic responses. Yet, CD4+ T cells are also known to be the main drivers of inflammatory bowel disease (IBD) when this balance is perturbed. Many subsets of CD4+ T cells have been identified as players in perpetuating chronic intestinal inflammation. Over the last few decades, understanding of how each subset of Th cells plays a role has dramatically increased. Simultaneously, this has allowed development of therapeutic innovation targeting specific molecules rather than broad immunosuppressive agents. Here, we review the emerging evidence of how each subset functions in promoting and sustaining the chronic inflammation that characterizes IBD.
Source: Frontiers in Immunology
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
Awards: Th9 cells in immediate hypersensitivity, Cytokine regulation of skin barrier function, Indiana Clinical and Translational Sciences Institute, Indiana Clinical and Translational Sciences Institute, Granzyme A-secreting T cells in allergic inflammation, Allergic inflammation and Transcriptional Regulation in Th9 cells
OpenAlex ID: W2806315338